D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Olin
OLN
$2.64B
| $136K | ﹤0.01% |
11,676
-418,553
| -97% | -$6.34M |
|
|
MRSN
3652
DELISTED
Mersana Therapeutics
MRSN
| $135K | ﹤0.01% |
926
-5,000
| -84% | -$874K |
|
|
IMMU
3653
CALL
DELISTED
Immunomedics Inc
IMMU
| $135K | ﹤0.01% |
+10,000
| New | +$168K |
|
|
GSB
3654
DELISTED
GlobalSCAPE, Inc.
GSB
| $135K | ﹤0.01% |
18,987
-5,228
| -22% | -$47.8K |
|
|
AHT
3655
Ashford Hospitality Trust
AHT
$21M
| $134K | ﹤0.01% |
181
-2
| -1% | -$4.16K |
|
3656
UNIFI
UFI
$117M
| $134K | ﹤0.01% |
11,568
-51,343
| -82% | -$1.05M |
|
|
RVI
3657
DELISTED
Retail Value Inc. Common Shares
RVI
| $134K | ﹤0.01% |
+118,967
| New | +$311K |
|
3658
CALL
KALA BIO
KALA
$11.8M
| $133K | ﹤0.01% |
6
| – | – |
|
|
FOE
3659
DELISTED
Ferro Corporation
FOE
| $131K | ﹤0.01% |
+13,958
| New | +$177K |
|
|
HAPN
3660
Happen Inc
HAPN
$2.08B
| $130K | ﹤0.01% |
+16,533
| New | +$184K |
|
3661
Pioneer Bancorp
PBFS
$445M
| $129K | ﹤0.01% |
12,392
-903
| -7% | -$12.3K |
|
3662
PUT
Regis Corp
RGS
$69.9M
| $129K | ﹤0.01% |
+1,090
| New | +$284K |
|
|
CDMO
3663
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $129K | ﹤0.01% |
25,332
-168,704
| -87% | -$1.02M |
|
|
SAVE
3664
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $129K | ﹤0.01% |
10,000
-39,100
| -80% | -$1.26M |
|
|
DRTT
3665
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
| $129K | ﹤0.01% |
127,300
-171,000
| -57% | -$392K |
|
3666
CALL
ATI
ATI
$27B
| $128K | ﹤0.01% |
+15,100
| New | +$241K |
|
3667
Spyre Therapeutics
SYRE
$8.87B
| $127K | ﹤0.01% |
+1,090
| New | +$185K |
|
|
NETI
3668
DELISTED
Eneti Inc.
NETI
| $127K | ﹤0.01% |
+5,005
| New | +$185K |
|
|
NLSN
3669
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $125K | ﹤0.01% |
10,000
| – | – |
|
3670
Liberty Energy
LBRT
$2.83B
| $124K | ﹤0.01% |
+45,977
| New | +$321K |
|
3671
A10 Networks
ATEN
$2.47B
| $123K | ﹤0.01% |
19,816
-23,874
| -55% | -$153K |
|
3672
Gran Tierra Energy
GTE
$260M
| $123K | ﹤0.01% |
48,982
-28,569
| -37% | -$227K |
|
3673
Hamilton Beach Brands
HBB
$302M
| $121K | ﹤0.01% |
12,731
-1,591
| -11% | -$22.2K |
|
|
PYX
3674
PUT
DELISTED
Pyxus International, Inc.
PYX
| $121K | ﹤0.01% |
+39,000
| New | +$207K |
|
3675
Cadiz
CDZI
$266M
| $120K | ﹤0.01% |
10,257
-38,192
| -79% | -$372K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.